Clinical Trial

Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics

Study acronym: NAP-RC
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Treatment with NSAI in renal colics has not been well investigated and there is no clear recommendations regarding this subject. The aim of this study is to determine if an oral NSAI treatment is beneficial in patients discharged for the emergency department after the first line treatment of a renal colic investigating the reccurence of pain, the reconsultation rates and the admissions.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-02-01; most recent amendment 2023-11-13.
Status change: Not Yet Recruiting → Recruiting 2023-05-13
Trial Details
NCT Number NCT05722782
Lead Sponsor University of Monastir
Conditions Renal Colic
Enrollment 500 participants
Start Date 2023-07-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2023-11-14